 Connection
Spyridon Mastroyannis to Neoplasm Staging
This is a "connection" page, showing publications Spyridon Mastroyannis has written about Neoplasm Staging.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.170 |
|
|
|
-
Nasioudis D, Mastroyannis SA, Ko EM, Haggerty AF, Cory L, Giuntoli RL, Kim SH, Morgan MA, Latif NA. Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database. Gynecol Oncol. 2022 08; 166(2):263-268.
Score: 0.040
-
Nasioudis D, Mastroyannis SA, Latif NA, Ko EM, Haggerty AF, Kim SH, Morgan MA, Giuntoli RL. Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis. Gynecol Oncol. 2020 06; 157(3):634-638.
Score: 0.035
-
Nasioudis D, Mastroyannis SA, Latif NA, Ko EM. Trends in the surgical management of malignant ovarian germcell tumors. Gynecol Oncol. 2020 04; 157(1):89-93.
Score: 0.034
-
Nasioudis D, Mastroyannis SA, Ko EM, Latif NA. Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer? Arch Gynecol Obstet. 2018 07; 298(1):179-182.
Score: 0.030
-
Nasioudis D, Mastroyannis SA, Albright BB, Haggerty AF, Ko EM, Latif NA. Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes. Gynecol Oncol. 2018 07; 150(1):14-18.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|